151 related articles for article (PubMed ID: 21718815)
1. Identification and characterization of the major alternative promoter regulating Bcrp1/Abcg2 expression in the mouse intestine.
Natarajan K; Xie Y; Nakanishi T; Beck WT; Bauer KS; Ross DD
Biochim Biophys Acta; 2011 Jul; 1809(7):295-305. PubMed ID: 21718815
[TBL] [Abstract][Full Text] [Related]
2. Bcrp1 transcription in mouse testis is controlled by a promoter upstream of a novel first exon (E1U) regulated by steroidogenic factor-1.
Xie Y; Natarajan K; Bauer KS; Nakanishi T; Beck WT; Moreci RS; Jeyasuria P; Hussain A; Ross DD
Biochim Biophys Acta; 2013 Dec; 1829(12):1288-99. PubMed ID: 24189494
[TBL] [Abstract][Full Text] [Related]
3. Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1.
Natarajan K; Xie Y; Nakanishi T; Moreci RS; Jeyasuria P; Hussain A; Ross DD
J Vis Exp; 2016 May; (111):. PubMed ID: 27286290
[TBL] [Abstract][Full Text] [Related]
4. Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.
Xie Y; Nakanishi T; Natarajan K; Safren L; Hamburger AW; Hussain A; Ross DD
Biochim Biophys Acta; 2015 Mar; 1849(3):317-27. PubMed ID: 25615818
[TBL] [Abstract][Full Text] [Related]
5. Expression of mouse Abcg2 mRNA during hematopoiesis is regulated by alternative use of multiple leader exons and promoters.
Zong Y; Zhou S; Fatima S; Sorrentino BP
J Biol Chem; 2006 Oct; 281(40):29625-32. PubMed ID: 16885162
[TBL] [Abstract][Full Text] [Related]
6. Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usage.
Nakanishi T; Bailey-Dell KJ; Hassel BA; Shiozawa K; Sullivan DM; Turner J; Ross DD
Cancer Res; 2006 May; 66(10):5007-11. PubMed ID: 16707421
[TBL] [Abstract][Full Text] [Related]
7. Intestinal expression of mouse Abcg2/breast cancer resistance protein (BCRP) gene is under control of circadian clock-activating transcription factor-4 pathway.
Hamdan AM; Koyanagi S; Wada E; Kusunose N; Murakami Y; Matsunaga N; Ohdo S
J Biol Chem; 2012 May; 287(21):17224-17231. PubMed ID: 22396548
[TBL] [Abstract][Full Text] [Related]
8. A novel xenobiotic responsive element regulated by aryl hydrocarbon receptor is involved in the induction of BCRP/ABCG2 in LS174T cells.
Tompkins LM; Li H; Li L; Lynch C; Xie Y; Nakanishi T; Ross DD; Wang H
Biochem Pharmacol; 2010 Dec; 80(11):1754-61. PubMed ID: 20804740
[TBL] [Abstract][Full Text] [Related]
9. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver.
Merino G; van Herwaarden AE; Wagenaar E; Jonker JW; Schinkel AH
Mol Pharmacol; 2005 May; 67(5):1765-71. PubMed ID: 15722455
[TBL] [Abstract][Full Text] [Related]
10. Expression of the breast cancer resistance protein (Bcrp1/Abcg2) in tissues from pregnant mice: effects of pregnancy and correlations with nuclear receptors.
Wang H; Wu X; Hudkins K; Mikheev A; Zhang H; Gupta A; Unadkat JD; Mao Q
Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1295-304. PubMed ID: 17082346
[TBL] [Abstract][Full Text] [Related]
11. Regulation of steroidogenesis and the steroidogenic acute regulatory protein by a member of the cAMP response-element binding protein family.
Manna PR; Dyson MT; Eubank DW; Clark BJ; Lalli E; Sassone-Corsi P; Zeleznik AJ; Stocco DM
Mol Endocrinol; 2002 Jan; 16(1):184-99. PubMed ID: 11773448
[TBL] [Abstract][Full Text] [Related]
12. Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein.
Allen JD; Van Dort SC; Buitelaar M; van Tellingen O; Schinkel AH
Cancer Res; 2003 Mar; 63(6):1339-44. PubMed ID: 12649196
[TBL] [Abstract][Full Text] [Related]
13. A mutation hot spot in the Bcrp1 (Abcg2) multidrug transporter in mouse cell lines selected for Doxorubicin resistance.
Allen JD; Jackson SC; Schinkel AH
Cancer Res; 2002 Apr; 62(8):2294-9. PubMed ID: 11956086
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition of murine Bcrp1/Abcg2 and human BCRP/ABCG2 by the mycotoxin fumitremorgin C.
González-Lobato L; Real R; Prieto JG; Alvarez AI; Merino G
Eur J Pharmacol; 2010 Oct; 644(1-3):41-8. PubMed ID: 20655304
[TBL] [Abstract][Full Text] [Related]
15. Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice.
Marchetti S; de Vries NA; Buckle T; Bolijn MJ; van Eijndhoven MA; Beijnen JH; Mazzanti R; van Tellingen O; Schellens JH
Mol Cancer Ther; 2008 Aug; 7(8):2280-7. PubMed ID: 18723475
[TBL] [Abstract][Full Text] [Related]
16. Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene.
Bailey-Dell KJ; Hassel B; Doyle LA; Ross DD
Biochim Biophys Acta; 2001 Sep; 1520(3):234-41. PubMed ID: 11566359
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the preprotachykinin-I gene promoter through a protein kinase A-dependent, cyclic AMP response element-binding protein-independent mechanism.
Calin-Jageman IE; Wang J; Bannon MJ
J Neurochem; 2006 Apr; 97(1):255-64. PubMed ID: 16515544
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer-resistance protein (BCRP1) in the fetal mouse brain: development and glucocorticoid regulation.
Petropoulos S; Gibb W; Matthews SG
Biol Reprod; 2011 Apr; 84(4):783-9. PubMed ID: 21159928
[TBL] [Abstract][Full Text] [Related]
19. ABCG2 expression, function, and promoter methylation in human multiple myeloma.
Turner JG; Gump JL; Zhang C; Cook JM; Marchion D; Hazlehurst L; Munster P; Schell MJ; Dalton WS; Sullivan DM
Blood; 2006 Dec; 108(12):3881-9. PubMed ID: 16917002
[TBL] [Abstract][Full Text] [Related]
20. The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study.
Zhou L; Naraharisetti SB; Wang H; Unadkat JD; Hebert MF; Mao Q
Mol Pharmacol; 2008 Mar; 73(3):949-59. PubMed ID: 18079276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
